Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Duque

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical Genitourinary Cancer|August 20, 2023
Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?Noelia Sanmamed, Juan Gómez-Rivas, David Buchser, et al.
World Journal of Urology|November 15, 2023
Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancerVictor Duque-Santana, Ana Diaz-Gavela, Manuel Recio, et al.
Biomedicines|August 28, 2025
Integrating Apparent Diffusion Coefficient and Prostate-Specific Antigen as Prognostic Factors of Treatment Response to Androgen Deprivation Therapy and Radiotherapy in Prostate CancerVictor Duque-Santana, Julio Fernandez, Fernando López-Campos, et al.
Clinical and Translational Radiation Oncology|December 1, 2025
Vascular calcifications in early-breast radiotherapy planning-CT: Opportunistic detection and cardiovascular risk assessmentAna Aurora Diaz-Gavela, Julio Fernández-Mata, Elia Del Cerro-Peñalver, et al.
Cancers|March 13, 2025
Apparent Diffusion Coefficient as an Early Predictive Factor of Local and Overall Response to Treatment with Androgen Deprivation Therapy and Radiotherapy in Patients with Prostate CancerVictor Duque-Santana, Julio Fernandez, Ana Diaz-Gavela, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 20, 2026
The role of SBRT as an ablative treatment in oligometastatic patientsBeatriz Debén Méndez, Marta Rodríguez Roldán, Maria Isabel Garrido Botella, et al.
European Journal of Cancer (Oxford, England : 1990)|October 17, 2024
Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour groupKhaled Elsayad, Emmanuella Guenova, Chalid Assaf, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 29, 2025
Management of high-risk prostate cancer in Spain: results from a national patterns of care surveyVictor Duque-Santana, Maria Antonia Gómez-Aparicio, Abrahams Ocanto, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Genitourinary Cancer|August 20, 2023
Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?Noelia Sanmamed, Juan Gómez-Rivas, David Buchser, et al.
World Journal of Urology|November 15, 2023
Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancerVictor Duque-Santana, Ana Diaz-Gavela, Manuel Recio, et al.
Biomedicines|August 28, 2025
Integrating Apparent Diffusion Coefficient and Prostate-Specific Antigen as Prognostic Factors of Treatment Response to Androgen Deprivation Therapy and Radiotherapy in Prostate CancerVictor Duque-Santana, Julio Fernandez, Fernando López-Campos, et al.
Clinical and Translational Radiation Oncology|December 1, 2025
Vascular calcifications in early-breast radiotherapy planning-CT: Opportunistic detection and cardiovascular risk assessmentAna Aurora Diaz-Gavela, Julio Fernández-Mata, Elia Del Cerro-Peñalver, et al.
Cancers|March 13, 2025
Apparent Diffusion Coefficient as an Early Predictive Factor of Local and Overall Response to Treatment with Androgen Deprivation Therapy and Radiotherapy in Patients with Prostate CancerVictor Duque-Santana, Julio Fernandez, Ana Diaz-Gavela, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 20, 2026
The role of SBRT as an ablative treatment in oligometastatic patientsBeatriz Debén Méndez, Marta Rodríguez Roldán, Maria Isabel Garrido Botella, et al.
European Journal of Cancer (Oxford, England : 1990)|October 17, 2024
Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour groupKhaled Elsayad, Emmanuella Guenova, Chalid Assaf, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 29, 2025
Management of high-risk prostate cancer in Spain: results from a national patterns of care surveyVictor Duque-Santana, Maria Antonia Gómez-Aparicio, Abrahams Ocanto, et al.
Pageof 2